Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine in Stress Urinary Incontinence
NCT00190996Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jan 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in stress urinary incontinence (SUI) comparing Duloxetine with Placebo (2 arms). Primary endpoint: Incontinence Episode Frequency at 12 weeks. Started Jan 2003; status: completed.
02
Drugs
duloxetine
03
Conditions
stress urinary incontinence (SUI)
Beyond the preview
Go deeper on NCT00190996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00190996.